Results for tag: "Liver Disease Drug"

The Liver Disease Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It is composed of drugs used to treat a variety of liver diseases, including hepatitis, cirrhosis, and fatty liver disease. These drugs are used to reduce inflammation, improve liver function, and reduce the risk of complications. Commonly used drugs include antivirals, immunosuppressants, and antifibrotics. In addition, some drugs are used to reduce the risk of liver cancer. The Liver Disease Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include AbbVie, Gilead Sciences, Merck, Pfizer, and Novartis. Other companies include Bristol-Myers Squibb, AstraZeneca, and Roche. Show Less Read more